Showing 1 - 17 results of 17 for search 'A Tincani', query time: 0.04s Refine Results
  1. 1
    The history of antiphospholipid syndrome

    The history of antiphospholipid syndrome by A. Tincani, G. Fontana, C. Mackworth-Young

    Published 2023-03-01
    Get full text
    Article
  2. 2
    Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations

    Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations by T. Ziglioli, S. Cartella, C. Casu, A. Tincani, R. Cattaneo

    Published 2011-06-01
    Get full text
    Article
  3. 3
    Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

    Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease by P.L. Meroni, F. Allegri, L. Andreoli, S. Piantoni, A. Tincani

    Published 2012-12-01
    Get full text
    Article
  4. 4
    Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

    Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience by R. Cattaneo, M. Ferrari, S. Archetti, L. Andreoli, M. Taraborelli, A. Tincani

    Published 2011-06-01
    Get full text
    Article
  5. 5
    Role of anti-prothrombin in antiphospholipid syndrome

    Role of anti-prothrombin in antiphospholipid syndrome by M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

    Published 2002-09-01
    Get full text
    Article
  6. 6
    Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?

    Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? by A. Tincani, I. Cavazzana, A. Ceribelli, M. Fredi, F. Inverardi, M. Taraborelli, F. Franceschini

    Published 2012-12-01
    Get full text
    Article
  7. 7
    Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

    Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus by A. Tincani, D. Villalta, M. Zen, A. Ghirardello, L. Iaccarino, L. Punzi, A. Doria

    Published 2012-12-01
    Get full text
    Article
  8. 8
    The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

    The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus by M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

    Published 2016-12-01
    Get full text
    Article
  9. 9
    PO.2.29 Serum levels of b-cell related factors belonging to the tnf/tnfr superfamily are lower in antiphospholipid-related syndromes than in systemic lupus erythematosus

    PO.2.29 Serum levels of b-cell related factors belonging to the tnf/tnfr superfamily are lower in antiphospholipid-related syndromes than in systemic lupus erythematosus by S Piantoni, L Andreoli, T Lowin, F Regola, F Franceschini, A Tincani, G Pongratz, S Bertocchi, E Pedretti, S Tamanini

    Published 2022-10-01
    Article
  10. 10
    Typing TREX1 gene in patients with systemic lupus erythematosus

    Typing TREX1 gene in patients with systemic lupus erythematosus by M. Fredi, M. Bianchi, L. Andreoli, G. Greco, I. Olivieri, S. Orcesi, E. Fazzi, C. Cereda, A. Tincani

    Published 2015-06-01
    Get full text
    Article
  11. 11
    Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center

    Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center by F. Dall'Ara, I. Cavazzana, M. Frassi, M. Taraborelli, M. Fredi, F. Franceschini, L. Andreoli, M. Rossi, C. Cattaneo, A. Tincani, P. Airò

    Published 2018-07-01
    Get full text
    Article
  12. 12
    Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

    Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I by P.L. Meroni, T. Avcin, A. Lojacono, M. Frassi, M. Nuzzo, W.L. Binder, G.L. Norman, M. Motta, C. Nalli, L. Andreoli, A. Tincani

    Published 2011-06-01
    Get full text
    Article
  13. 13
    P6.18 CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS; ARE THERE ANY DIFFERENCES?

    P6.18 CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS; ARE THERE ANY DIFFERENCES? by A. Paini*, L. Andreoli, M. Salvetti, F. Dall’Ara, S. Piantoni, C. Donini, C. Agabiti Rosei, F. Bertacchini, D. Stassaldi, E. Agabiti Rosei, A. Tincani, M.L. Muiesan

    Published 2015-11-01
    Get full text
    Article
  14. 14
    Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

    Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1 by P.L. Meroni, T. Avcin, V. Medeghini, A. Meini, A. Lojacono, M. Frassi, M. Nuzzo, Z. Shums, W.L. Binder, G.L. Norman, M. Motta, L. Andreoli, C. Nalli, A. Tincani

    Published 2011-09-01
    Get full text
    Article
  15. 15
    3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES

    3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES by C. De Ciuceis, C. Rossini, E. La Boria, S. Duse, F. Semeraro, C. Agabiti Rosei, P. Airò, M. Scarsi, A. Tincani, M.L. Muiesan, A. Paini, M. Salvetti, E. Porteri, E. Agabiti Rosei, D. Rizzoni

    Published 2012-11-01
    Get full text
    Article
  16. 16
    Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies

    Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies by M. Frassi, A. Brucato, I. Cavazzana, F. Franceschini, D. Faden, M. Motta, A. Doria, R. Cimaz, M.P. Pisoni, M. Muscarà, G. Castellino, G. Brambilla, P.L. Meroni, R. Cattaneo, C. Biasini Rebaioli, C. Antonioli, G. Balestrieri, A. Tincani

    Published 2001-12-01
    Get full text
    Article
  17. 17
    New EULAR guidelines about treatment systemic lupus eritematosus

    New EULAR guidelines about treatment systemic lupus eritematosus by G Bertsias, J Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I Gilboe, F Houssiau, T Huizinga, D Isenberg, C Kallenberg, M Khamashtau, J Piette, M Schneider, J Smolen, G Sturfelt, A Tincani, R van Vollenhoven, C Gordon, D Boumpas

    Published 2008-02-01
    Get full text
    Article

Search Tools: